News & Insights
The latest on investor advocacy.
Newest first
May 2026
Going Concern, Going Missing: How the Auditor’s Most Important Opinion Disappeared as Bankruptcies Climbed
Borrowed Liquidity: How Private Markets Are Reaching the American 401(k)
and What Plan Fiduciaries Must Demand Before They Sign the Next Investment Policy Statement
Workouts Without Witnesses: How Liability Management Exercises Have Quietly Reordered the Capital Structure
and What Institutional Investors Must Demand Before the Next Uptier
Collateral Damage: How Insider Pledged Shares Have Quietly Built a Fault Line Beneath the AI Boom
and What Institutional Investors Must Demand from the Proxy Statement
Choice of State: How the Migration of Corporations from Delaware Is Recasting Stockholder Rights
and What Institutional Investors Must Demand Before They Vote on the Next Reincorporation Proxy
April 2026
Marks Without a Market: How the Saba Tender Offers Exposed the Architecture of Private Credit Valuations
and What Institutional Investors Must Now Demand
The Useful Life Question: A Forensic Framework for Reading Hyperscaler Depreciation Policy in the Artificial Intelligence Capital Expenditure Era
The Performance Paradox: How Executive Compensation Became Corporate America’s Best-Engineered Guarantee
and What Institutional Investors Must Demand from the Proxy Statement
The Hidden Ledger: How Supply Chain Finance Became Corporate America’s Most Dangerous Off-Balance-Sheet Liability
and Why Most Investors Still Cannot See It
March 2026
The Tariff Fog: How Trade Policy Chaos Became Corporate America’s Most Convenient Cover for Financial Statement Manipulation
and What Institutional Investors Must Do to See Through It
The Buyback Mirage: How $1 Trillion in Annual Share Repurchases Became Corporate America’s Most Powerful
and Least Scrutinized—Earnings Management Tool
Powered by Artificial Intelligence, Built on Artificial Claims: How AI Washing Became America’s Newest Securities Fraud
and How Forensic Investors Can Detect It
The Last Line of Defense: How the Disappearance of Activist Short Sellers Is Leaving Corporate Fraud Undetected
and What Institutional Investors Must Do About It
The Buxton Helmsley Brief.
Research, campaign updates, and market commentary, delivered as they publish.